Liver Metastasis Treatment Market to Reach US$ 3.3 Billion, Growing at 6.5% CAGR by 2034 | Fact.MR Report
December 10, 2024 07:00 ET
|
FACT.MR
Rockville, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global liver metastasis treatment market is estimated to reach a...
Nano Drug Delivery System (NDDS) in Cancer Therapy Global Industry Research Report 2024 - Global Forecast to 2030 with Competitive Profiles of 45+ Key Players
December 03, 2024 10:04 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "NDDS in Cancer Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for NDDS in...
Chemotherapy-induced Nausea and Vomiting Drugs Industry Research Business Report 2024: Market to Surpass $5 Billion by 2030 - Antiemetic Drug Formulations, & Quality of Life Focus Drives Demand
December 03, 2024 09:53 ET
|
Research and Markets
Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy-induced Nausea and Vomiting Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
Esophageal Cancer Competitive Landscape Analysis Report 2024: Pipeline has 571 Molecules Across All Stages of Development - Commercial Assessment, Deals, Pricing and Reimbursement, Marketed Drugs
November 28, 2024 11:22 ET
|
Research and Markets
Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "Esophageal Cancer: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of...
Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report
November 20, 2024 07:30 ET
|
FACT.MR
Rockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global metastatic colorectal cancer market is estimated to reach a...
Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001
November 19, 2024 04:00 ET
|
AKAMPION
THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activityData presented at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024 Munich,...
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - Develop Comprehensive Care Protocols & Improve Access to Treatments
October 25, 2024 10:56 ET
|
Research and Markets
Dublin, Oct. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By...
Checkpoint Inhibitor Refractory Cancer (PD-L1 and PD-1) Market Research Report 2024-2030: Biomarker Testing Revolutionizes Treatment, Personalized Medicine and Immunotherapy Bolster Growth
October 23, 2024 06:33 ET
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Checkpoint Inhibitor Refractory Cancer Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application, End-User,...
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
October 15, 2024 08:00 ET
|
Immuneering Corporation
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
Chemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030
October 14, 2024 10:54 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.A...